S3326 Continuation of Mesalamine with Anti-Tumor Necrosis Factor in Inflammatory Bowel Disease: A Two Center Analysis of Treatment Trends and Cost. (October 2021) - Sehmbey, Gurbir; Fawcett, Janet; Alishahi, Yasmin; Nanda, Rakesh